- Home
- RSSS vs TIL Comparison
RSSS vs TIL Comparison
Compare RSSS & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- TIL
- Stock Information
- Founded
- RSSS 2006
- TIL 2018
- Country
- RSSS United States
- TIL United States
- Employees
- RSSS N/A
- TIL N/A
- Industry
- RSSS Business Services
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- TIL Health Care
- Exchange
- RSSS Nasdaq
- TIL Nasdaq
- Market Cap
- RSSS 131.6M
- TIL 134.5M
- IPO Year
- RSSS N/A
- TIL 2021
- Fundamental
- Price
- RSSS $3.86
- TIL $19.61
- Analyst Decision
- RSSS Strong Buy
- TIL Strong Buy
- Analyst Count
- RSSS 1
- TIL 4
- Target Price
- RSSS $6.00
- TIL $114.00
- AVG Volume (30 Days)
- RSSS 169.0K
- TIL 103.6K
- Earning Date
- RSSS 02-06-2025
- TIL 11-13-2024
- Dividend Yield
- RSSS N/A
- TIL N/A
- EPS Growth
- RSSS N/A
- TIL N/A
- EPS
- RSSS N/A
- TIL N/A
- Revenue
- RSSS $46,607,410.00
- TIL N/A
- Revenue This Year
- RSSS $13.30
- TIL N/A
- Revenue Next Year
- RSSS $8.35
- TIL $2.64
- P/E Ratio
- RSSS N/A
- TIL N/A
- Revenue Growth
- RSSS 19.26
- TIL N/A
- 52 Week Low
- RSSS $2.38
- TIL $9.62
- 52 Week High
- RSSS $4.24
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- RSSS 50.39
- TIL 42.58
- Support Level
- RSSS $3.64
- TIL $18.56
- Resistance Level
- RSSS $4.00
- TIL $22.00
- Average True Range (ATR)
- RSSS 0.19
- TIL 2.05
- MACD
- RSSS -0.06
- TIL 0.27
- Stochastic Oscillator
- RSSS 36.67
- TIL 13.49
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.